Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ISBT Working Party on Information Technology Guideline on external electronic communication of transfusion traceability information.

Vox sanguinis·2026
Same author

Successful autologous T cell apheresis in pediatric patients with hematologic malignancies, solid tumors, and brain tumors.

Cytotherapy·2026
Same author

Tracing the gaps: A global snapshot.

Vox sanguinis·2026
Same author

Gene duplication is associated with gene diversification and potential neofunctionalization in lung cancer evolution.

Genome research·2026
Same author

How do I implement a whole blood program with low blood wastage?

Transfusion·2025
Same author

The impact of age and gravidity on CD34+ yields in female peripheral blood stem cell donors.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2025

Related Experiment Video

Updated: Jul 11, 2026

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
09:29

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on: February 1, 2013

ISBT 128 implementation plan for cellular therapy products.

Paul Ashford, Pat Distler, Adrian Gee

    Journal of Clinical Apheresis
    |September 8, 2007
    PubMed
    Summary

    New global standards for cellular therapy terminology and labeling are published. This paper guides organizations on implementing these standards, covering project management, equipment, and validation for better traceability.

    More Related Videos

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
    09:34

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

    Published on: August 16, 2021

    Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
    12:40

    Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

    Published on: December 7, 2012

    Related Experiment Videos

    Last Updated: Jul 11, 2026

    Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
    09:29

    Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

    Published on: February 1, 2013

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
    09:34

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

    Published on: August 16, 2021

    Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
    12:40

    Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

    Published on: December 7, 2012

    Area of Science:

    • Biotechnology
    • Regulatory Science
    • Cellular Therapy

    Background:

    • Global consistency and traceability are crucial for cellular therapies.
    • New standards for terminology and labeling have been published to address this need.
    • Widespread implementation is key to realizing the benefits of these standards.

    Purpose of the Study:

    • Provide practical guidance for adopting new cellular therapy standards.
    • Address organizations with varying levels of computerization.
    • Facilitate the successful implementation of global terminology and labeling standards.

    Main Methods:

    • Discussion of project management strategies for standard implementation.
    • Analysis of equipment requirements for compliance.
    • Review of licensing and validation processes.
    • Guidance tailored to different organizational computerization levels.

    Main Results:

    • A framework for practical implementation of new cellular therapy standards.
    • Considerations for diverse organizational infrastructures.
    • Strategies for overcoming common adoption challenges.

    Conclusions:

    • Successful implementation of new cellular therapy standards requires careful planning and execution.
    • Guidance is provided to ensure consistency and traceability globally.
    • Organizations can leverage this information to adapt to new regulatory requirements.